Literature DB >> 32082515

Signature of Gut Microbiome by Conventional and Advanced Analysis Techniques: Advantages and Disadvantages.

Sama Rezasoltani1, Dorrieh Ahmadi Bashirzadeh1, Ehsan Nazemalhosseini Mojarad2, Hamid Asadzadeh Aghdaei2, Mohsen Norouzinia1, Shabnam Shahrokh1.   

Abstract

Gut microbiota is considered as a human organ with its own specific functions and complexity. Development of novel techniques such as shut gun sequencing, metagenomics, and next-generation sequencing (NGS) has enabled bypassing the traditional culturedependent bias and has significantly expanded our understanding of the composition, diversity, and roles of the gut microbiota in human health and diseases. Although amplicon sequencing characterizes the taxonomic composition of the gut microbiome, it is impossible to cover the direct evidence of the microbial biological functions related to the gut microbial community. Hence, the critical next step for gut microbiome studies is shifting from gene/ genome-centric analysis to mechanism-centric techniques by integrating omics data with experimental results. Realizing gut microbial diversity and their bioactive metabolites function will provide insight into the clinical application of gut microbiota in diagnoses and treatments of several diseases. In this review, we focused on explaining the conventional and advanced microbiome analysis techniques regarding gut microbiota investigation with considering the advantages and disadvantages of the platforms.
© 2020 The Author(s).

Entities:  

Keywords:  Advantages; Disadvantages; Gut microbiota; Microbiome analysis techniques

Year:  2020        PMID: 32082515      PMCID: PMC7023644          DOI: 10.15171/mejdd.2020.157

Source DB:  PubMed          Journal:  Middle East J Dig Dis        ISSN: 2008-5230


INTRODUCTION

Gut microbiota

The new organ, the last human organ, a forgotten organ, or a missing organ, all of these names remark the important role of gut microbiota.[1,2] They can be explained as a community of bacteria, archea, viruses, fungi, and protozoa. Predominating human gastrointestinal tract microbiota consists of firmicutes, proteobacteria, bacteroidetes , actinobacteria, fusobacteria, verromicrobia, and cyanobacteria.[3] An altered gut microbiome composition not only has been shown linked to the gastrointestinal disorders such as colorectal polyps,[4] colorectal cancer (CRC),[5,6] and celiac disease,[7] but also is associated with non-intestinal disorders such as allergy,[8] asthma,[9,10] obesity,[11,12] non-alcoholic fatty liver,[13] cardiovascular diseases,[13,14] and neuropsychiatric diseases.[15-17] These disorders can be attributed to the imbalance of the gut microbiota, which would be referred to as dysbiosis (dysbacteriosis) or dysregulation of gut microbiota.[16]

Conventional gut microbiome analysis techniques: advantages and disadvantages

A link to the gut microbiome and diseases was first postulated in the 20th century. However, until the 1990s, understanding of the gut microbiome was confined because the microbiological culture was the only way to investigate its composition. Actually, a small fraction of the gut microbiota has been cultured up to now and developments in culture-independent techniques have led to our belief of the complexity of this microenvironment. These techniques have clarified the gut microbiota diversity and composition and have shown that dysbacteriosis and dysregulation of gut microbiota are associated with several diseases. These latest techniques are rapid, accurate, and comfort high throughput to identify and enumerate uncultivable microorganisms.[18] These techniques are based on sequence divergences of the small subunit ribosomal RNA (16S rRNA) that are well conserved between various species of bacteria and provide bacterial species identification and demonstrate gut microbiota diversity. Also, they provide qualitative and quantitative information on bacterial species and gut microbiota alteration in relation to diseases. Examples of these conventional analysis techniques are quantitative real-time polymerase chain reaction (q PCR), denaturing gradient gel electrophoresis (DGGE), terminal restriction fragment length polymorphism (T-RFLP), fluorescence in situ hybridization (FISH), 16S rRNA gene sequencing-based on cloning, direct sequencing of 16S rRNA amplicons, shotgun sequencing (table 1).[19,20]
Table 1

Conventional gut microbiome analysis techniques considering their strengths and weaknesses

Technique Explanation Strength Weakness
Culture Cultivation of selected bacteria on selective mediaInexpensive, semi-quantitative method A small fraction of gut microbiota has been cultured up to now, labor-intensive
Quantitative real-time polymerase chain reaction (q PCR) Quantification of 16S rRNA. Reaction mixture includes a compound that fluoresces when it binds to double-stranded DNARapid, phylogenetic characterization, quantitative methodPCR bias, incapable of characterizing unknown species
Denaturing gradient gel electrophoresis (DGGE)Gel separation of 16S rRNA amplicons using denaturant/ temperatureSemi-quantitative, bands could be applied for further analysis, rapidPCR bias, no phylogenetic characterization
Terminal restriction fragment length polymorphism (T-RFLP)Fluorescently labeled primers are quantified and then restriction enzymes are applied to digest the 16S rRNA amplicon. Digested fragments further separated by gel electrophoresisInexpensive, fast, semi-quantitative methodPCR bias, no phylogenetic characterization, low resolution
Fluorescence in situ hybridization (FISH) Fluorescently labeled oligonucleotide probes hybridize complementary target 16S rRNA sequences. When hybridization occurs, fluorescence can be enumerated using flow cytometryNo PCR bias, Phylogenetic characterization, semi-quantitative methodRelated to probe sequences— incapable of characterizing unknown species
16S rRNA gene sequencing based on cloningSanger sequencing, capillary electrophoresis, cloning of full-length 16S rRNA ampliconPhylogenetic characterization, quantitative methodExpensive, PCR bias, laborious, cloning bias
Direct sequencing of 16S rRNA ampliconsLarge parallel sequencing of partial 16S rRNA amplicons Rapid, phylogenetic characterization, quantitative method, capable of identifying unknown bacteriaPCR bias, expensive, laborious
Shotgun sequencingMassive parallel sequencing of the whole genome Phylogenetic characterization, quantitative methodExpensive, analysis of data is computationally intense

Microbiome shotgun sequencing and metagenomics

Despite applying 16S rRNA technology has significantly improved our knowledge of gut microbiota composition and diversity; it has not illuminated the significant association between microbial patterns and disease initiation or progression. In fact, metagenomics demonstrates the newest growth in gut microbiota composition analysis. It has been widely used in studies including the human microbiome project (HMP).[21-23] This technique is capable of sequencing all the DNA fragments in the sample rather than the sequencing of particular DNA fragments.[24,25] This method is used to analyze the composition and diversity of gut microbiota by data sequencing from the merged genomes of the microbiota. The strength of the technique is that it is strong enough to identify new functional genes. On the other hand, the weakness of the technique is that it cannot provide gene expression profiles and predict how different conditions can regulate it also cannot distinguish DNA of live cells from DNA of dead cells.[26,27] Whole-genome shotgun metagenomic sequencing is a widely used tool for characterizing the metagenomic content of gut microbiome samples. While whole-genome shotgun metagenomic sequencing data contains gene-level information, it can be an incentive to analyze the millions of microbial genes, which are typically found in microbiome experiments. It is performed by major parallel sequencing of the mixed DNA sample. It implicates random fragmentation of DNA, sequencing of DNA fragments and reconstruction of overlapping sequences to assemble them into a continuous sequence. The advantage of the technique is that information is assembled on the genetic diversity of the gut microbiota. Information on the genetic diversity and composition of the gut microbiota permits correlations to be made between gut microbiota and disease position. Disadvantages of shotgun metagenomics sequencing are that it is costly and also the analysis of a large amount of data is computationally intense and not easily performed in general laboratories.[28,29]

Next-generation sequencing (NGS) in gut microbiota study

NGS technologies in particular targeted amplicon sequencing of the 16S-seq and enabled the identification and quantification of human-resident microorganisms at unprecedented resolution, providing novel insights into the role of the microbiota in health and disease. The ability to rapidly sequence human genomes and to generate genetic, transcriptomic, and epigenetic data and other genome-wide data for a relatively small cost opens up numerous opportunities for translation into the clinic over the next few years.[30,31] NGS as a high throughput procedure has revolutionized the human gut microbiota studies and enabled the exploration of uncultured gut microbial diversity communities as a sufficient and cost-effective technique.[32,33] It consists of the following techniques: 454 GS FLX + (Roche), HiSeq 2000/2500 (lumina), 5500 xl SOLiD (Life Technologies), PacBio RS (Pacific Bioscience), Ion torrent (Life Technologies).[34] Figure 1 depicts NGS technology upon PCR or non-PCR based.
Fig.1
Diagram for different NGS platforms technologies Actually the procedure is amplicon-based profiling and is applied as one of the most widely used techniques for defining gut microbiome diversity. Usually, 16S rRNA for bacteria and archaea as a taxonomically informative gene marker is prevalent for organisms to be studied, targeted, and amplified from the total DNA. The resulting amplicons are sequenced, and downstream bioinformatics analyses are performed to characterize the relative taxonomical abundances in the samples.[34-36] There are many advantages and disadvantages related to applying NGS platforms (table 2).[30]
Table 2

NGS platforms considering the strengths and weaknesses[34]

Machinery Chemistry Strengths Weakness
454 Gs Flx + (Roche)PyrosequencingRead length is long, sensitive, analysis of multiple samples at the same time, no cloning biasIn hands-genes, expensive, the high error rate in homopolymers, short sequencing reads, extensive, bioinformatics analysis require
HighSeq (2000/25000) (Illumina) Quantification of 16S rRNA. Reaction mixture includes a compound that fluoresces when it binds to double-stranded DNA Rapid, phylogenetic characterization, quantitative method PCR bias, incapable of characterizing unknown species
5500 SOLiD (Life technologies) Ligation Low error rate, high throughputShort length, long process
PacBio RS (Pacific Bioscience)Real-time sequencingEasy preparation, cheap, long read length High error rate, expensive, difficult installation
- Ion torrent (Life Technologies)Proton detection Short process, flexible chip reagentsInstrument under development
In a one-run, pyrosequencing sequences 500 million bases with more than 99% accuracy rate.[37] NGS platform compares gene marker profiles across samples in order to identify microbial diversity. Although amplicon sequencing characterizes the taxonomic composition of the gut microbiome, it is impossible to cover the direct evidence of the microbial biological metabolites and functions, which are related to the gut microbial community. Hence, important next step for gut microbiome studies is shifting from genome-based analysis to mechanism-based techniques by integrating omics data with these results.[35] Alongside, metagenomics, metabolomics, proteomics, transcriptomics, and phenomics data are important for investigating gut microbiome characterization, functions, metabolites, proteins, and RNA.[38,39]

Omics techniques: advantages and disadvantages

By gathering metagenomics, metabolomics, proteomics, transcriptomics, and phenomics data we will reach more realization on the functioning besides diversity of the gut microbiota. The integrative analysis of these omics data will be critical for understanding the host-microbiome interaction mechanisms (table 3).
Table 3

Omics gut microbiome analysis techniques considering the strengths and weaknesses

Techniques: Metaomics Explanation Strength Weakness
Metagenomics Investigating gut microbiota genomes profiling in highresolution, characterization of genesstructures of uncultivatedmicrobiota Comprehensive sequence data, data of functional contributions of the microbiota, needless to cloning of specific genesThe function of gut microbiota are not generated
Metatranscriptomics Messenger RNA/cDNA sequencing for high-resolution gene expressionprofiling, differential microbial gene in expression variousphysiological/environmental situations High throughput, high sensitivity, quantification method, characterization of known andunknown gut microbiota, evaluation of microbial interaction Lack of unique protocol,low stability of microbialmRNA, representativelyunknown/ multiplepurification steps needed
Metaproteomics Proteins/Peptides are identified for high resolution protein monitoring and profiling, differential microbial proteinsproduction under various physiological/environmental conditions Locating and monitoring newfunctional genes Lack of unique protocol,unknown proteins indatabases, heterogeneous stability
MetabolomicsMetabolites are analyzed for microbial host metabolic profilingRapid and easy to perform on every low amount of specimens including faces/serum/urine, time-efficient, the impact of gut microbiota in health and disease Lack of unique protocol, unknown metabolites in databases, strict characterization ofcompound labor-intensive, the combination of host and bacterial molecules

Data analysis and bioinformatics approaches

The first step for the analysis of the microbiota is to determine the evolutionary association among the microbiota in the gut. Both alignments dependent based and alignment independent based techniques are applied to specify the evolutionary relatedness between them. In the alignment-based analysis, the homologous positions in the gene sequence are identified through a multiple sequence alignment against databases such as Ribosomal Database Project II (RDPII). The most general method for manufacturing alignments is the CLUSTAL online software and databases such as NCBI and multivariate statistical analysis are employed in this way. One of the advantages of the alignment dependent based method is that it is the most precise approach to permit a detailed map of the phylogenetic relations, but it is not suitable for analysis of large data sets. However alternative methods applied for large datasets can be cost-effective. Presently, the most used method for alignment independent based technique analysis is principal component analysis.[26]

CONCLUSION

With the newest technologies including microbiome shotgun sequencing, metagenomics, and NGS platforms, a deep understanding of the gut microbiome diversity has been gained, but it is impossible to cover direct evidence of the microbial biological metabolites and functions, which are related to the gut microbial community, along with their role in initiation and progression of diseases. Hence, the critical next step for gut microbiome studies is shifting from genome-based analysis to mechanism-based techniques by integrating omics data with experimental results. Therefore, there is a critical demand to go beyond solely characterizing the gut microbiome composition, systematic modeling, and analysis of the gut microbiome metabolites and function. Generally, understanding gut microbial diversity and their bioactive metabolites function in different types of disorders will provide insight into the clinical application of gut microbiota in diagnoses and treatments of diseases.
  37 in total

Review 1.  Gut microbiota in health and disease.

Authors:  Inna Sekirov; Shannon L Russell; L Caetano M Antunes; B Brett Finlay
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

Review 2.  A microbial world within us.

Authors:  Erwin G Zoetendal; Elaine E Vaughan; Willem M de Vos
Journal:  Mol Microbiol       Date:  2006-03       Impact factor: 3.501

Review 3.  The role of infectious mediators and gut microbiome in the pathogenesis of celiac disease.

Authors:  Mohammad Rostami Nejad; Sauid Ishaq; David Al Dulaimi; Mohammad Reza Zali; Kamran Rostami
Journal:  Arch Iran Med       Date:  2015-04       Impact factor: 1.354

4.  Measuring the diversity of the human microbiota with targeted next-generation sequencing.

Authors:  Francesca Finotello; Eleonora Mastrorilli; Barbara Di Camillo
Journal:  Brief Bioinform       Date:  2018-07-20       Impact factor: 11.622

Review 5.  Application of metagenomics in the human gut microbiome.

Authors:  Wei-Lin Wang; Shao-Yan Xu; Zhi-Gang Ren; Liang Tao; Jian-Wen Jiang; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

6.  Microbiota and SCFA in lean and overweight healthy subjects.

Authors:  Andreas Schwiertz; David Taras; Klaus Schäfer; Silvia Beijer; Nicolaas A Bos; Christiane Donus; Philip D Hardt
Journal:  Obesity (Silver Spring)       Date:  2009-06-04       Impact factor: 5.002

7.  Environmental genome shotgun sequencing of the Sargasso Sea.

Authors:  J Craig Venter; Karin Remington; John F Heidelberg; Aaron L Halpern; Doug Rusch; Jonathan A Eisen; Dongying Wu; Ian Paulsen; Karen E Nelson; William Nelson; Derrick E Fouts; Samuel Levy; Anthony H Knap; Michael W Lomas; Ken Nealson; Owen White; Jeremy Peterson; Jeff Hoffman; Rachel Parsons; Holly Baden-Tillson; Cynthia Pfannkoch; Yu-Hui Rogers; Hamilton O Smith
Journal:  Science       Date:  2004-03-04       Impact factor: 47.728

Review 8.  The gut microbiota in neuropsychiatric disorders.

Authors:  Marta Grochowska; Marcin Wojnar; Marek Radkowski
Journal:  Acta Neurobiol Exp (Wars)       Date:  2018       Impact factor: 1.579

Review 9.  High-throughput bacterial genome sequencing: an embarrassment of choice, a world of opportunity.

Authors:  Nicholas J Loman; Chrystala Constantinidou; Jacqueline Z M Chan; Mihail Halachev; Martin Sergeant; Charles W Penn; Esther R Robinson; Mark J Pallen
Journal:  Nat Rev Microbiol       Date:  2012-08-06       Impact factor: 60.633

Review 10.  Metagenome, metatranscriptome, and metaproteome approaches unraveled compositions and functional relationships of microbial communities residing in biogas plants.

Authors:  Julia Hassa; Irena Maus; Sandra Off; Alfred Pühler; Paul Scherer; Michael Klocke; Andreas Schlüter
Journal:  Appl Microbiol Biotechnol       Date:  2018-04-30       Impact factor: 4.813

View more
  5 in total

Review 1.  Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.

Authors:  Sama Rezasoltani; Abbas Yadegar; Hamid Asadzadeh Aghdaei; Mohammad Reza Zali
Journal:  Cancer Med       Date:  2020-12-25       Impact factor: 4.452

2.  Associations between self-reported psychological symptom severity and gut microbiota: further support for the microgenderome.

Authors:  Michael Ganci; Emra Suleyman; Henry Butt; Michelle Ball
Journal:  BMC Psychiatry       Date:  2022-04-30       Impact factor: 4.144

Review 3.  Inborn errors of immunity and related microbiome.

Authors:  Raja Hazime; Fatima-Ezzohra Eddehbi; Saad El Mojadili; Nadia Lakhouaja; Ikram Souli; Abdelmouïne Salami; Bouchra M'Raouni; Imane Brahim; Mohamed Oujidi; Morad Guennouni; Ahmed Aziz Bousfiha; Brahim Admou
Journal:  Front Immunol       Date:  2022-09-13       Impact factor: 8.786

4.  Effects of Dietary Maltol on Innate Immunity, Gut Health, and Growth Performance of Broiler Chickens Challenged With Eimeria maxima.

Authors:  Inkyung Park; Doyun Goo; Hyoyoun Nam; Samiru S Wickramasuriya; Kichoon Lee; Noah P Zimmerman; Alexandra H Smith; Thomas G Rehberger; Hyun S Lillehoj
Journal:  Front Vet Sci       Date:  2021-05-20

5.  Fecal microbiota transplantation and antibiotic treatment attenuate naloxone-precipitated opioid withdrawal in morphine-dependent mice.

Authors:  Ana C Thomaz; Vishakh Iyer; Taylor J Woodward; Andrea G Hohmann
Journal:  Exp Neurol       Date:  2021-06-18       Impact factor: 5.620

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.